Substance Use Evaluation for Licensed Professionals in Minnesota

Independent, private-pay clinical evaluation conducted by secure telehealth across Minnesota.

Substance use evaluations conducted in connection with professional licensure matters carry consequences that differ in kind from other forensic and clinical assessment contexts. The resulting documentation may inform decisions about licensure standing, conditions of practice, return to clinical or professional work, employer-mandated programs, and ongoing monitoring relationships that extend over years. The integrity of the evaluation — its methodological rigor, the structural independence of the evaluator, and the evidentiary clarity of the report — directly affects the professional's standing in the regulated decision-making contexts the report will reach.

Arlucent Assessments provides independent, private-pay substance use evaluations for licensed professionals in Minnesota across a range of licensure contexts. Evaluations are conducted by secure telehealth and follow the American Society of Addiction Medicine (ASAM) Criteria, Minnesota DHS 245G regulatory standards, and DSM-5/ICD-10 diagnostic conventions. The practice is assessment-only — no treatment, no therapy, no referrals to affiliated programs, no continuing clinical relationship.

Substance use evaluations commissioned through Arlucent Assessments™ for licensure-adjacent contexts operate the Screening, Tracking, and Analysis layers of the STABLE™ architecture. The evaluation produces a structured clinical baseline supported by the practice's structural independence; the assessment tier determines the depth of behavioral coherence measurement; and the synthesis produces the analytic record the licensing authority, the monitoring program, the employer, and counsel rely upon. 

Arlucent Assessments is not currently on the Minnesota Health Professionals Services Program (HPSP) approved evaluator panel. Licensed professionals whose licensure context specifically requires an HPSP-designated evaluator should be directed to the HPSP-approved panel for that purpose. Similar designated-evaluator requirements exist in some licensing-board and employer-mandated contexts and should be confirmed through the referring authority before scheduling an evaluation with any independent provider.

Arlucent Assessments provides substance use evaluations in licensure-adjacent contexts where independent evaluation is appropriate or specifically required. These include independent review of HPSP evaluations or other designated-evaluator findings, second opinion evaluations on prior licensure-related assessments, evaluations for employer-mandated contexts that accept independent evaluators, evaluations for licensing-board processes in professions whose boards accept independent evaluators or operate without a designated-evaluator panel, return-to-practice evaluations where the regulating authority accepts independent documentation, and pre-emptive evaluations conducted at the professional's initiative prior to a regulatory or employer disclosure event.

Whether a particular licensure matter falls within the practice's scope is confirmed at intake. The intake review identifies whether the operative authority requires a designated evaluator, what the documentation requirements are, and whether the case is appropriately served by the practice or should be directed elsewhere.

A licensed professional anticipates a regulatory disclosure event — a complaint response, a licensure renewal question, a self-report obligation, or an employer disclosure — and wishes to obtain an independent clinical picture before engaging the regulatory or employer process. Pre-emptive evaluation supports the professional's deliberation about disclosure, response strategy, and any voluntary actions that may be appropriate prior to formal proceedings. The resulting documentation is held by the professional and is not transmitted to any third party absent the professional's authorization.

A prior evaluation conducted by a designated evaluator, an employer-selected clinician, or a treatment-program-affiliated assessor has produced findings the professional or counsel wishes to have independently reviewed. Independent review applies the ASAM dimensional framework to the documented clinical picture and the records underlying it, and produces a parallel clinical document that can be presented alongside the original in the regulated decision-making context. Independent reviews in licensure contexts are typically conducted at the ACA or ACSA tier; this use case is also addressed on the practice's Independent Second Opinion Assessment page.

A professional who has been away from practice — due to substance use, treatment, licensure action, voluntary leave, or other circumstances — requires an evaluation to support return-to-work consideration by the licensing authority, monitoring program, or employer. Return-to-practice evaluations differ from initial licensure-threshold or fitness-for-duty evaluations in their clinical question: rather than establishing the presence or severity of a substance use condition at a single point in time, the evaluation addresses the trajectory of the professional's situation over the period of absence, the documented engagement with relevant clinical or recovery resources during that period, and the alignment between current presentation and the demands of the role to which the professional is returning. The report is structured to support return-to-work decision-making rather than to characterize the initial circumstances that gave rise to the absence.

A hospital system, group practice, law firm, agency, or other employer has required a substance use evaluation as a condition of continued employment, return from leave, or response to an internal review. Employer-mandated evaluations are operationally similar to board-mandated evaluations in their clinical methodology but differ in audience and reporting: the report is delivered to the professional and, with appropriate authorization, to the employer. The professional's interests and the employer's interests are clearly distinguished in the report structure.

A professional who has undergone a designated evaluation (HPSP, a licensing-board-designated evaluator, or analogous) and whose evaluation has produced findings they wish to have independently reviewed may pursue an independent second opinion. Independent second opinions in this context do not replace the designated evaluation — the designated evaluation remains the authority-recognized document — but provide a parallel clinical reference point that the professional, counsel, and decision-making authorities may weigh.

Licensure-context evaluations follow the same structured methodology applied across the practice's assessment tiers. The evaluation consists of a structured clinical interview, review of relevant history (substance use history, prior assessments and treatment, mental health history, medical context, and the specific licensure or employment circumstances giving rise to the evaluation), standardized screening data where indicated, and — when authorized and relevant — review of collateral documentation including prior assessments, treatment records, drug testing records, licensure-related filings, and employer documentation.

The ASAM Criteria evaluate six clinical dimensions: acute intoxication and withdrawal potential, biomedical conditions and complications, emotional and behavioral conditions, readiness to change, relapse and continued use potential, and recovery environment. These dimensions are applied as a structured analytic framework to produce a clinically reasoned picture of severity, risk, and service need. When indicated by the clinical picture, a level-of-care opinion may be included; such opinions reflect the evaluating clinician's professional judgment at the time of assessment and do not constitute placement authorization, utilization review, or treatment mandate.

Reports in licensure contexts are structured to distinguish documented evidence, structured clinical analysis, and evaluator conclusions — a structural feature designed to support evidentiary clarity in regulated decision-making contexts. Diagnostic conclusions are documented with severity specifiers and the evidentiary basis on which they rest. The report does not adopt advocacy posture and does not produce conclusions about licensure standing, employment decisions, or other determinations that fall outside the scope of clinical assessment; these determinations are reserved to the operative licensing or employment authority.

The Minnesota substance use assessment market includes a structural feature that bears direct mention in the licensure context, because licensed professionals are uniquely positioned to evaluate it: many assessments are conducted by clinicians employed by, or financially affiliated with, treatment programs that subsequently provide the recommended services. The assessor and the service provider are, in those cases, parts of the same organization. This arrangement is permitted under Minnesota regulatory standards and is not inherently improper, but it introduces a structural conflict that licensed professionals — trained to recognize and manage analogous conflicts in their own practice — reasonably weigh when selecting an evaluator for their own licensure matter.

Arlucent Assessments operates without that structural feature. The practice provides no treatment, no therapy, no aftercare, no referrals to affiliated programs, and no continuing clinical relationship. The evaluating clinician's role concludes with delivery of the written report. There is no organizational benefit to recommending any particular level of care, any particular monitoring intensity, or any particular conclusion about the professional's circumstances. This is the structural condition under which the evaluation can function as an independent clinical document in licensure, employer, and monitoring contexts.

Independent second opinion and review services are typically conducted at the ACA or ACSA tier. The ASAA tier, which provides regulatory-standard documentation aligned with Minnesota DHS 245G, is appropriate when the second opinion needs to be presented in a regulated context that expects the standard assessment format. Most independent reviews, however, involve diagnostic complexity, contested clinical reasoning, or multi-system considerations that the ACA and ACSA tiers are designed to address.

The Arlucent Clinical Assessment (ACA) is appropriate for second opinions involving a single prior assessment, a clearly defined clinical question, and a single primary use context (court, licensure, family court, or treatment decision). The ACA incorporates narrative formulation and a structured snapshot of The Arlucent Seventh Dimension™, the practice's proprietary analysis of behavioral coherence and value-behavior alignment, which is particularly relevant in cases where the prior assessment's level-of-care recommendation rests on inferences about motivation, readiness, or recovery environment.

The Arlucent Comprehensive Systems Assessment™ (ACSA) is the capstone tier and is appropriate for high-complexity second opinion work — cases involving multiple prior assessments with divergent findings, co-occurring conditions, professional licensure matters, complex custody proceedings, or situations in which the report will be relied upon by multiple decision-making parties (court, licensing authority, employer, family system) simultaneously. The ACSA integrates full ASAM synthesis with a complete multi-domain application of The Arlucent Seventh Dimension™.

Detailed methodology and tier specifications are documented on the Methodology page. Further information on the behavioral coherence framework is available on the Arlucent Seventh Dimension™ page.

 All licensure-context evaluations follow the practice's defined intake and evaluation process. The intake questionnaire is the first step — a brief confidential review used to confirm that the case is within scope, that the operative authority does not specifically require a designated evaluator, and that the appropriate assessment tier and documentation scope can be determined. Following intake review, eligible requests are confirmed, consent materials and scope parameters are provided in writing, and required documentation is requested in advance of scheduling.

Confidentiality is structured to protect the professional. Reports are delivered to the professional. Transmission of the report to any third party — licensing authority, employer, monitoring program, counsel, or other — occurs only with the professional's written authorization, and the scope of that authorization is documented. Pre-emptive evaluations conducted at the professional's initiative are held by the professional and are not transmitted absent explicit authorization. Where the evaluation is conducted under an employer mandate or with a pre-existing release to a regulating authority, the documentation flow is confirmed at intake.

Scheduled appointments are confirmed only after payment is received. Reports are delivered as written clinical documents formatted for use in the contexts they are intended to inform.

Evaluations are conducted by Rafael Lewis, M.A., LADC, an independent clinical assessor licensed in Minnesota and the founder of Arlucent Assessments. Mr. Lewis is a doctoral student in counseling psychology at Saint Mary's University of Minnesota and is the developer of The Arlucent Seventh Dimension™ (PFI), the proprietary behavioral coherence framework integrated across the practice's assessment tiers. His clinical and administrative experience includes leadership roles in licensed substance use treatment settings, providing direct working knowledge of the regulatory standards, documentation conventions, and structural considerations relevant to professional licensure evaluation contexts.

Additional information on credentialing, professional accountability, and scope of practice is available on the About page.

Determining whether an independent licensure-context evaluation is appropriate for your specific circumstances begins with the intake questionnaire. The questionnaire is brief, confidential, and used to confirm that the case is within the practice's scope, to identify the appropriate assessment tier, and to clarify whether the operative authority requires a designated evaluator. Documentation requirements, scheduling, and payment are confirmed in writing following intake review.

Scheduled appointments are confirmed only after payment is received.